Diseases requiring anatomical lobectomy or segmentectomy Lung cancer, Metastatic lung tumors, Infections, Benign lung tumors
Conditions
Interventions
Conduct routine preoperative examinations, and if eligibility criteria are met, obtain informed consent to participate in the trial and then perform screening tests. Registration must be completed by
E04.928
thoracic surgery
Sponsors
Suzuki Hidemi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age is between 18 and 90 years at the time of informed consent. 2) The patient is scheduled to undergo anatomical lung resection (lobectomy or segmentectomy). 3) ECOG performance status (PS) is 0-1. 4) Major organ function is preserved. 5) Preoperative chest CT examination was performed within 90 days of the scheduled surgery date. 6) Written informed consent for participation in this study has been obtained from the patient.
Exclusion criteria
Exclusion criteria: 1) Cases scheduled for wedge resection. 2) Patients with a history of thoracic surgery on the same side. 3) Patients requiring surrogate decision-making, such as those with dementia. 4) Patients with a history of hypersensitivity or allergic reactions to the devices to be used. 5) Other cases deemed inappropriate for the safe conduct of this trial by the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence or absence of exudative hemorrhage from the pulmonary artery and pulmonary vein resection stumps | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary efficacy endpoints 1) Grade of modified Likert scale for all pulmonary vessels resected using an automatic suturing device within the same case 2) Hemostasis method 3) Intraoperative blood loss (ml) 4) Number of automatic suturing devices used for pulmonary vessel resection (units) 5) Surgeon 6) Final surgical procedure Secondary safety endpoints Incidence of adverse events during and after surgery | — |
Contacts
Public ContactRyo Karita
Chiba University Hospital
Outcome results
None listed